New SPECT imaging for brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new imaging agent (99mTc-CNDG) to see if it can help doctors see brain tumors better on a SPECT/CT scan. It might provide more information than standard scans and could help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a brain tumor diagnosed by a doctor.
- You must be 18 years old or older.
- You must be able to have surgery or a biopsy to confirm the tumor type.
- You must not have diabetes that requires insulin, and your blood sugar must be under 7 mmol/L before the scan.
- You must not have severe liver or kidney problems.
- You must not be pregnant or breastfeeding.
- You must not have severe anxiety in enclosed spaces (claustrophobia).
- You must not be currently receiving radiation therapy or chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
This trial tests a new imaging method that uses a special dye to highlight a protein called Trop-2 found on some brain tumor cells. The goal is to see if this dye can help doctors see the tumor more clearly before surgery, which may improve surgical planning.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study tests a new imaging agent that may help doctors see solid tumor cancers more clearly on a special scan. If you have or may have a solid tumor, this scan could provide more information about your condition.
This trial tests a new imaging tracer that may help doctors see brain tumors (gliomas) more clearly before surgery. It could help guide treatment and is for people scheduled for surgery or biopsy.
Hear when a new Intracranial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.